68th American Academy of Neurology Annual Meeting

68th American Academy of Neurology Annual Meeting | AAN 2016

The AAN Annual Meeting is billed as "the world's largest gathering of neurologists, bringing together more than 10,000 neurology professionals across the globe." It provides attendees the chance "to network, discuss cutting-edge research, and take part in top-rated education programing across a wide variety of topics."

Conference Coverages

Computerized Spoon That Benefits Parkinson's Disease Patients Can Also Help Neurologists
Computerized Spoon That Benefits Parkinson's Disease Patients Can Also Help Neurologists
A battery-operated Liftware utensil was developed in 2014 to help Parkinson’s disease patients manage their hand tremors and conquer daily activities.
Sleep Problems Affect Decreased Brain Volume
Older adults who suffer from sleep problems also experience reduced brain volume, new research finds.
Migraines Can Impact Complications in Birth
Pregnant women who obtain treatment for acute migraine experience higher rates of preeclampsia, preterm delivery, and deliver babies with low birth-weight.
More Medical Complaints Before a Concussion Could Affect Recovery Time in Athletes
Athletes with psychosomatic symptoms or medical complaints like aches and pains without concrete physical causes can prolong recovery time after suffering a concussion.
Epilepsy Does Not Affect Conception, New Research Finds
A long held myth that epilepsy interferes with conception has been busted.
Frank Conidi: Working Toward a Safer Future in Sports Medicine VIDEO
Whether it is learning from the military or finding consensus among the governing bodies of youth and scholastic sports there are steps that can be taken to make them safe and help limit the risk of injuries and concussions.
Frank Conidi: Studying Concussions in Retired NFL Players and Looking at the Future of Football VIDEO
The issue of concussions and potential brain damage has made considerable headlines in recent years. What the cause and diagnosis of these issues are remain to be determined.
Edward Fox from the MS Clinic of Central Texas: Alemtuzumab's Long-Term Studies Show Efficacy for Multiple Sclerosis Treatment VIDEO
With a unique delivery method alemtuzumab, also known as Lemtrada has proven to be an effective treatment option for multiple sclerosis. While careful monitoring is required new data has shown benefits for the right patient population.
Further Analysis of the Benefits of Deflazacort in Patients with Duchenne Muscular Dystrophy
Researchers at the American Academy of Neurology’s 68th Annual Meeting reported analyses of the phase III trial of the investigational glucocorticoid (deflazacort/Marathon Pharmaceuticals), which was previously found to improve muscle strength in Duchenne Muscular Dystrophy (DMD) patients.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$